DelistingJul 10, 2026, 04:07 PM
ENvue Medical Faces Nasdaq Delisting Due to Bid Price Non-Compliance
AI Summary
ENvue Medical, Inc. received a notice from Nasdaq on July 10, 2026, indicating non-compliance with the minimum bid price requirement. The company's common stock traded below $1.00 for 30 consecutive business days. Due to a reverse stock split in August 2025, ENvue Medical is not eligible for the standard 180-day compliance period. The company plans to request a hearing to appeal Nasdaq's determination.
Key Highlights
- ENvue Medical received a Staff Determination Letter from Nasdaq on July 10, 2026.
- The company's common stock bid price was below $1.00 for 30 consecutive business days (May 26, 2026, to July 8, 2026).
- This violates Nasdaq Listing Rule 5550(a)(2) Minimum Bid Price Requirement.
- The company is not eligible for the usual 180-day compliance period under Nasdaq Listing Rule 5810(c)(3)(A)(iv).
- Ineligibility is due to a 1-for-10 reverse stock split effected on August 12, 2025.
- ENvue Medical intends to appeal the determination to the Nasdaq Hearings Panel.
Price Impact
More from FEED